{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:17:10Z","timestamp":1648513030163},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1007\/s11938-001-0057-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T13:46:02Z","timestamp":1180878362000},"page":"317-322","source":"Crossref","is-referenced-by-count":2,"title":["Nonulcer dyspepsia"],"prefix":"10.1007","volume":"4","author":[{"given":"Guy E. E.","family":"Boeckxstaens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"suppl 2","key":"57_CR1","first-page":"II37","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading RC, et al.: Functional gastroduodenal disorders. Gut 1999, 45(suppl 2):II37-II42. A key article that describes the current definition and subclasses of functional dyspepsia.","journal-title":"Gut"},{"key":"57_CR2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1046\/j.1365-2036.2000.00862.x","volume":"14","author":"P Bytzer","year":"2000","unstructured":"Bytzer P, Hallas J: Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther 2000, 14:1479\u20131484.","journal-title":"Aliment Pharmacol Ther"},{"key":"57_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","volume":"356","author":"AT Lassen","year":"2000","unstructured":"Lassen AT, Pedersen FM, Bytzer P, et al.: Helicobacter pylori test- and -eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000, 356:455\u2013460. A well-designed large trial, illustrating that the test-and-treatment approach for H. pylori infection is as safe as prompt endoscopy in patients with functional dyspepsia.","journal-title":"Lancet"},{"key":"57_CR4","first-page":"G1217","volume":"277","author":"SD Kuiken","year":"1999","unstructured":"Kuiken SD, Samsom M, Camilleri M, et al.: Development of a test to measure gastric accommodation in humans. Am J Physiol 1999, 277:G1217-G1221.","journal-title":"Am J Physiol"},{"key":"57_CR5","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1572-0241.1999.01281.x","volume":"94","author":"V Stanghellini","year":"1999","unstructured":"Stanghellini V, Tosetti C, Paternico A, et al.: Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999, 94:2080\u20132085.","journal-title":"Am J Gastroenterol"},{"key":"57_CR6","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346\u20131352.","journal-title":"Gastroenterology"},{"key":"57_CR7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V Stanghellini","year":"1996","unstructured":"Stanghellini V, Tosetti C, Paternico A, et al.: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110:1036\u20131042.","journal-title":"Gastroenterology"},{"key":"57_CR8","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1023\/A:1005550019308","volume":"45","author":"PL Rhee","year":"2000","unstructured":"Rhee PL, Kim YH, Son HJ, et al.: Evaluation of individual symptoms cannot predict presence of gastric hypersensitivity in functional dyspepsia. Dig Dis Sci 2000, 45:1680\u20131684.","journal-title":"Dig Dis Sci"},{"key":"57_CR9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1440-1746.2000.02080.x","volume":"15","author":"BF Werdmuller","year":"2000","unstructured":"Werdmuller BF, van der Putten TB, Balk TG, et al.: Clinical presentation of Helicobacter pylori-positive and -negative functional dyspepsia. J Gastroenterol Hepatol 2000, 15:498\u2013502.","journal-title":"J Gastroenterol Hepatol"},{"key":"57_CR10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Pare P, et al.: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998, 12:1055\u20131065.","journal-title":"Aliment Pharmacol Ther"},{"key":"57_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gut.47.4.473","volume":"47","author":"AL Blum","year":"2000","unstructured":"Blum AL, Arnold R, Stolte M, et al.: Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut 2000, 47:473\u2013480. A well-designed large trial showing a beneficial effect of omeprazole but not of ranitidine in a very large group of patients with functional dyspepsia.","journal-title":"Gut"},{"key":"57_CR12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/003655299750026010","volume":"34","author":"V Meineche-Schmidt","year":"1999","unstructured":"Meineche-Schmidt V, Talley NJ, Pap A, et al.: Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol 1999, 34:566\u2013574.","journal-title":"Scand J Gastroenterol"},{"key":"57_CR13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1572-0241.1998.00368.x","volume":"93","author":"JM Hansen","year":"1998","unstructured":"Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB: Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998, 93:368\u2013374.","journal-title":"Am J Gastroenterol"},{"key":"57_CR14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004836-199806000-00022","volume":"26","author":"JS Finney","year":"1998","unstructured":"Finney JS, Kinnersley N, Hughes M, et al.: Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998, 26:312\u2013320.","journal-title":"J Clin Gastroenterol"},{"key":"57_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.2000.00742.x","volume":"14","author":"C Mansi","year":"2000","unstructured":"Mansi C, Borro P, Giacomini M, et al.: Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000, 14:561\u2013569.","journal-title":"Aliment Pharmacol Ther"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"NJ Talley","year":"2000","unstructured":"Talley NJ, Verlinden M, Snape W, et al.: Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000, 14:1653\u20131661. A large trial that clearly shows that ABT-229, a motilin agonist, is not superior to placebo.","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl 1","key":"57_CR17","doi-asserted-by":"crossref","first-page":"I28","DOI":"10.1136\/gut.45.2008.i28","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ: How should Helicobacter pylori positive dyspeptic patients be managed? Gut 1999, 45(suppl 1):I28-I31.","journal-title":"Gut"},{"key":"57_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"JL Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108:65\u201372.","journal-title":"Am J Med"},{"key":"57_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J Hamilton","year":"2000","unstructured":"Hamilton J, Guthrie E, Creed F, et al.: A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000, 119:661\u2013669. This is an important study evaluating the effect of psychotherapy. It shows benefit from psychotherapy at 1-year follow-up, but only after excluding patients with severe heartburn from the analysis.","journal-title":"Gastroenterology"},{"key":"57_CR20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"NW Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664\u2013668.","journal-title":"Gut"},{"key":"57_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11938-000-0042-7","volume":"3","author":"J Tack","year":"2000","unstructured":"Tack J: Functional dyspepsia: impaired fundic accommodation. Curr Treat Option Gastroenterol 2000, 3:287\u2013294.","journal-title":"Curr Treat Option Gastroenterol"},{"key":"57_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.46.4.468","volume":"46","author":"J Tack","year":"2000","unstructured":"Tack J, Coulie B, Wilmer A, et al.: Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000, 46:468\u2013473.","journal-title":"Gut"},{"key":"57_CR23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","volume":"48","author":"C Feinle","year":"2001","unstructured":"Feinle C, Meier O, Otto B, et al.: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48:347\u2013355.","journal-title":"Gut"},{"key":"57_CR24","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1365-2036.2000.00873.x","volume":"14","author":"B May","year":"2000","unstructured":"May B, Kohler S, Schneider B: Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 2000, 14:1671\u20131677.","journal-title":"Aliment Pharmacol Ther"},{"key":"57_CR25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1365-2036.1999.00644.x","volume":"13","author":"G Holtmann","year":"1999","unstructured":"Holtmann G, Gschossmann J, Karaus M, et al.: Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 1999, 13:1459\u20131465.","journal-title":"Aliment Pharmacol Ther"},{"key":"57_CR26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/gut.48.1.14","volume":"48","author":"J Serra","year":"2001","unstructured":"Serra J, Azpiroz F, Malagelada JR: Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001, 48:14\u201319.","journal-title":"Gut"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-001-0057-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0057-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:56Z","timestamp":1559422616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-001-0057-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s11938-001-0057-8","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}